As a compounded preparation, it has not undergone FDA review for safety, effectiveness, or manufacturing quality as a finished product, and it should not be treated as equivalent to Ozempic or Wegovy - those are the FDA-approved, brand-name semaglutide products, manufactured and reviewed separately by Novo Nordisk
GLP-1 & GIP weight loss medications functions by targeting two key receptors in the body: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
pic.twitter.com/TdULLYwzXB RAND (@RANDCorporation) August 6, 2025 Large national surveys asking adults directly whether they are taking GLP-1 drugs show that women are more likely than men to be current users
Such interactions may influence cell shape, motility, and remodeling, offering a foundation for exploring cytoskeletal regulation in controlled systems
That is why our Doral clinic prescribes CJC-1295/Ipamorelin and does not offer Sermorelin
Only 1% reported using GLP-1 medications for weight loss